Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) Director William Federici sold 1,493 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the transaction, the director directly owned 26,991 shares of the company’s stock, valued at €461,276.19. The trade was a 5.24% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Stevanato Group Stock Performance
NYSE STVN opened at €17.79 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21. Stevanato Group S.p.A. has a fifty-two week low of €12.89 and a fifty-two week high of €28.00. The business has a fifty day moving average of €17.47 and a 200-day moving average of €17.26. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of 30.15, a price-to-earnings-growth ratio of 1.69 and a beta of 0.78.
Stevanato Group (NYSE:STVN – Get Free Report) last posted its quarterly earnings data on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). The company had revenue of €273.57 million for the quarter. Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The firm’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.10 earnings per share. As a group, analysts predict that Stevanato Group S.p.A. will post 0.68 earnings per share for the current fiscal year.
Stevanato Group Cuts Dividend
Analyst Ratings Changes
A number of research firms have recently weighed in on STVN. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Weiss Ratings raised shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, June 18th. Wolfe Research started coverage on Stevanato Group in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price target for the company. Citigroup reduced their price target on Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, March 5th. Finally, KeyCorp lowered their price objective on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, March 5th. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy”.
Read Our Latest Stock Report on STVN
Institutional Trading of Stevanato Group
A number of institutional investors and hedge funds have recently made changes to their positions in STVN. GW&K Investment Management LLC raised its position in shares of Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after buying an additional 1,055 shares during the period. Fifth Third Bancorp grew its position in Stevanato Group by 22.6% during the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after acquiring an additional 773 shares during the period. State of Wyoming increased its stake in Stevanato Group by 39,216.7% during the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after acquiring an additional 2,353 shares during the last quarter. Quantbot Technologies LP acquired a new stake in Stevanato Group during the third quarter worth about $68,000. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Stevanato Group by 1,268.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock worth $112,000 after purchasing an additional 4,250 shares during the period.
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Featured Stories
- Five stocks we like better than Stevanato Group
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
